Agathos Biologics

 

James Brown, Ph.D., CEO & Co-founder

Oct. 9 | 9:15am | FLW Ballroom G 

Fargo, North Dakota

(Private)

Agathos Biologics is a biotechnology company pursuing transformational science in biomanufacturing, biologic payload delivery, and cell and gene therapy. Discoveries in bioprocessing and genetic characterization and control have created an abundance of scientific possibilities that can help us all lead better lives. Agathos has developed a proprietary cell line, AE1-BHK, for the production of recombinant adeno-associated viral vectors (rAAV). AE1-BHK is a potential alternative to HEK293 and avoids the ethical concerns regarding the use of cells derived from aborted fetal tissue. Our mission as the good science company is to create breakthrough products and services within a strong ethical and moral framework that benefit everyone. We believe in science that serves and have a relentless focus on serving our clients, employees, and society.

www.agathos.bio



By using this website you agree to accept our Privacy Policy and Terms & Conditions